Home › Kanser sa Prostate › Connecticut
Pag-aaral pangklinika para sa Kanser sa Prostate sa Connecticut
29 pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa mga site sa Connecticut.
Mga Lungsod sa Connecticut
- New Haven22 pag-aaral
- East Norwalk16 pag-aaral
- Hartford7 pag-aaral
- Bridgeport7 pag-aaral
- Stamford5 pag-aaral
Opisyal na teksto ng pag-aaral (English)
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale-New Haven Hospital-Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- at 2 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT04557449A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
- Yale Cancer Center, New Haven
Nagre-recruitPhase 1/2
Edad 18 pataas · Kalalakihan · Na-update Nob 5, 2026 · NCT07567846Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Stamford Hospital/Bennett Cancer Center, Stamford
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06632977Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Yale University, New Haven
Nagre-recruitPhase 1/2
Edad 18 pataas · Kalalakihan · Na-update Nob 3, 2026 · NCT06800313A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
- Yale Cancer Center, New Haven
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Nob 3, 2026 · NCT05800665A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
- Hartford Healthcare Alliance (Data collection only), Hartford
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Okt 30, 2026 · NCT05751434A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Yale-New Haven Hospital-Yale Cancer Center ( Site 0050), New Haven
- Veterans Affairs Connecticut Healthcare System ( Site 0062), West Haven
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 30, 2026 · NCT06925737Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Yale New Haven Hospital, New Haven
Nagre-recruitPhase 1
Edad 18 hanggang 100 · Kalalakihan · Na-update Okt 29, 2026 · NCT05519449A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Yale Cancer Center, New Haven
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06172478A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Yale-New Haven Hospital-Yale Cancer Center ( Site 0064), New Haven
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT06136650A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Hartford HealthCare Cancer Institute at Hartford Hospital, Hartford
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 20, 2026 · NCT07213674Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Smilow Cancer Hospital Care Center - Guilford, Guilford
- Yale University, New Haven
- Stamford Hospital/Bennett Cancer Center, Stamford
- at 3 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 8, 2026 · NCT03678025FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Yale University School of Medicine, New Haven
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT05919264A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
- GSK Investigational Site, New Haven
Nagre-recruitPhase 1/2
Edad 18 pataas · Kalalakihan · Na-update Okt 5, 2026 · NCT06990880The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Yale Cancer Center, New Haven
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Hartford Hospital, Hartford
Nagre-recruitPhase 2/3
Edad 18 hanggang 100 · Kalalakihan · Na-update Set 22, 2026 · NCT06780670High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Set 17, 2026 · NCT05011383The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
- Yale Cancer Center, New Haven
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Set 14, 2026 · NCT06111781A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth
- Wren Laboratories, Branford
Nagre-recruitObservasyonal na pag-aaral
Edad 45 hanggang 80 · Kalalakihan · Na-update Ago 21, 2026 · NCT07454603A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- New Haven Hospital - Yale Cancer Center, New Haven
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Ago 17, 2026 · NCT06842498Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Hul 14, 2026 · NCT06592924Integrated Cancer Repository for Cancer Research
- Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
- Yale University (Data Collection Only), New Haven
Nagre-recruitPhase 1/2
Edad 18 pataas · Kalalakihan · Na-update Hun 25, 2026 · NCT06457919Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Hartford Hospital, Hartford
Nagre-recruitPhase 4
Edad 18 hanggang 100 · Kalalakihan · Na-update Hun 4, 2026 · NCT05803941International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Yale University, New Haven
Nagre-recruitObservasyonal na pag-aaral
Edad 21 pataas · Kalalakihan · Na-update May 22, 2026 · NCT03151629A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Yale University, Yale Cancer Center, New Haven
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 27, 2026 · NCT06395519Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- Smilow Cancer Hospital-Derby Care Center, Derby
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury
- at 11 pa
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Ene 29, 2026 · NCT05806515SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hartford
- Massive Bio SYNERGY-AI site, Norwalk
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.